Revive Therapeutics Ltd. (RVVTF)
OTCMKTS
· Delayed Price · Currency is USD
0.0215
-0.0012 (-5.11%)
Apr 28, 2025, 3:24 PM EDT
Revive Therapeutics Statistics
Total Valuation
RVVTF has a market cap or net worth of 9.07 million. The enterprise value is 9.03 million.
Market Cap | 9.07M |
Enterprise Value | 9.03M |
Important Dates
The next estimated earnings date is Wednesday, May 28, 2025.
Earnings Date | May 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +15.37% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 412.24M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 2.04 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.45 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.06
Current Ratio | 0.06 |
Quick Ratio | 0.02 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -398.29 |
Financial Efficiency
Return on equity (ROE) is -66.49% and return on invested capital (ROIC) is -22.73%.
Return on Equity (ROE) | -66.49% |
Return on Assets (ROA) | -16.18% |
Return on Invested Capital (ROIC) | -22.73% |
Return on Capital Employed (ROCE) | -45.15% |
Revenue Per Employee | n/a |
Profits Per Employee | -1.84M |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.38% in the last 52 weeks. The beta is 2.10, so RVVTF's price volatility has been higher than the market average.
Beta (5Y) | 2.10 |
52-Week Price Change | +2.38% |
50-Day Moving Average | 0.01 |
200-Day Moving Average | 0.01 |
Relative Strength Index (RSI) | 66.75 |
Average Volume (20 Days) | 469,541 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -2.03M |
Pretax Income | -3.68M |
Net Income | -3.68M |
EBITDA | -2.03M |
EBIT | -2.03M |
Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 38,514 in cash and n/a in debt, giving a net cash position of 38,514.
Cash & Cash Equivalents | 38,514 |
Total Debt | n/a |
Net Cash | 38,514 |
Net Cash Per Share | n/a |
Equity (Book Value) | 4.44M |
Book Value Per Share | 0.01 |
Working Capital | -2.11M |
Cash Flow
Operating Cash Flow | -1.81M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
RVVTF does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -15.37% |
Shareholder Yield | -15.37% |
Earnings Yield | -40.58% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |